Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-6-30
pubmed:abstractText
The current study was carried out to elucidate the immunoregulatory changes induced by venom immunotherapy (VIT) in bee or wasp allergic subjects. All subjects included in this study had a history of severe systemic allergic reactions to stings of the respective insect as well as positive skin tests with the respective venom or venom-specific IgE in the sera. Parameters assessed in peripheral blood mononuclear cells (PBMC) before and after initiation of VIT (rush therapy reaching a maintenance dose of 100 micrograms venom injected subcutaneously within 1 week) were expression of CD3, CD4, CD8, CD45RA, CD45RO, interleukin (IL)-2 receptor (R) alpha, IL-4R, IL-12R, Fc epsilon RII, CD40, and CD40 ligand (CD40L), cells producing interferon (IFN)-gamma and IL-10 after stimulation with phorbol 12-myristate 13-acetate + ionomycin in the presence of monensin measured by flow cytometry; secretion of IFN-gamma, IL-4, and IL-10 measured by ELISA (IFN-gamma and IL-10 were additionally measured by PCR), and proliferation after stimulation with the respective venom. Significant decreases were observed after VIT for proliferative response to venom and venom + IL-4, IL-4 secretion, Fc epsilon RII, CD40, and CD40L expression. Significant increases were observed after VIT for IFN-gamma concerning the amount secreted and the number of producing cells, and IL-10, IL-10 was mainly produced by CD4+ cells that were negative for IFN-gamma, but some double-positive (IL-10 and IFN-gamma) cells were always detected. Addition of blocking anti-IL-10 antibodies, but not isotype control antibodies, prevented down-regulation of proliferation (but not IL-4 secretion) and further enhanced IFN-gamma secretion after VIT. These data indicate that in insect venom allergic subjects, VIT not only induces a rapid shift in cytokine expression from Th2 to Th1 cytokines, but also leads to induction of the immunosuppressive cytokine IL-10, which may be important for the limitation of potentially harmful allergen-specific Th1 responses. The described changes in cytokine expression may be responsible for subsequent increases in allergen-specific IgG and decreases in IgE production, as well as suppressive activity observed in earlier studies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Allergens, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD40, http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Surface, http://linkedlifedata.com/resource/pubmed/chemical/Bee Venoms, http://linkedlifedata.com/resource/pubmed/chemical/CD40 Ligand, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-10, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-4, http://linkedlifedata.com/resource/pubmed/chemical/Ligands, http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, IgE, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-4, http://linkedlifedata.com/resource/pubmed/chemical/Wasp Venoms
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0014-2980
pubmed:author
pubmed:issnType
Print
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1131-9
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:9174602-Allergens, pubmed-meshheading:9174602-Antibodies, Monoclonal, pubmed-meshheading:9174602-Antigens, CD, pubmed-meshheading:9174602-Antigens, CD40, pubmed-meshheading:9174602-Antigens, Surface, pubmed-meshheading:9174602-Bee Venoms, pubmed-meshheading:9174602-CD40 Ligand, pubmed-meshheading:9174602-Desensitization, Immunologic, pubmed-meshheading:9174602-Down-Regulation, pubmed-meshheading:9174602-Humans, pubmed-meshheading:9174602-Insect Bites and Stings, pubmed-meshheading:9174602-Interferon-gamma, pubmed-meshheading:9174602-Interleukin-10, pubmed-meshheading:9174602-Interleukin-4, pubmed-meshheading:9174602-Ligands, pubmed-meshheading:9174602-Lymphocyte Activation, pubmed-meshheading:9174602-Lymphocyte Count, pubmed-meshheading:9174602-Membrane Glycoproteins, pubmed-meshheading:9174602-RNA, Messenger, pubmed-meshheading:9174602-Receptors, IgE, pubmed-meshheading:9174602-Receptors, Interleukin, pubmed-meshheading:9174602-Receptors, Interleukin-4, pubmed-meshheading:9174602-T-Lymphocyte Subsets, pubmed-meshheading:9174602-Th1 Cells, pubmed-meshheading:9174602-Th2 Cells, pubmed-meshheading:9174602-Time Factors, pubmed-meshheading:9174602-Wasp Venoms
pubmed:year
1997
pubmed:articleTitle
Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
pubmed:affiliation
Department of Dermatology, University of Mainz, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't